Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Shawn G. Kwatra(University of Maryland, Baltimore), Sonja Ständer(Klinik für Schlafmedizin), Christophe Piketty(Galderma (Switzerland)), Hilde Lapeere(Johns Hopkins University), Gil Yosipovitch(University of Miami), Vivian Laquer(Johns Hopkins University), S. Barbarot(Hotel Dieu Hospital), Rola Gharib(Johns Hopkins University), E. Serra‐Baldrich(Universitat Autònoma de Barcelona), Curdin Conrad(University of Lausanne), Walter K. Nahm(Johns Hopkins University), Adam Reich(Rzeszów University of Technology), Franz J. Legat(Medical University of Graz), Dagmar Simon(University of Bern), Jacek C. Szepietowski(Wroclaw Medical University), Luigi Naldi(Centro Studi GISED), Maxwell Sauder(Johns Hopkins University), C. Paul(Université Fédérale de Toulouse Midi-Pyrénées), L. Misery(Centre Hospitalier Régional Universitaire de Brest), Alan B. Fleischer(University of Cincinnati Medical Center), Zarif K. Jabbar Lopez(Johns Hopkins University), Marjolein de Bruin‐Weller(Netherlands Center for Occupational Diseases), Faiz Ahmad(Galderma (United States)), Charles Lynde(University of Toronto)
Cited by 184
Related Papers
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
|Journal of Investigative Dermatology|2014|954
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Clinical Classification of Itch: a Position Paper of the International Forum for the Study of Itch
|Acta Dermato Venereologica|2007|748